(0.73%) 5 119.50 points
(0.11%) 38 329 points
(1.00%) 17 744 points
(0.66%) $84.12
(-3.91%) $1.574
(0.56%) $2 355.70
(0.67%) $27.54
(0.47%) $924.80
(0.16%) $0.933
(0.49%) $11.01
(-0.01%) $0.799
(-0.19%) $92.00
Live Chart Being Loaded With Signals
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally...
Stats | |
---|---|
Today's Volume | 25 165.00 |
Average Volume | 72 206.00 |
Market Cap | 173.29M |
EPS | $0 ( 2024-03-07 ) |
Next earnings date | ( $-0.0400 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.94 |
ATR14 | $0.0480 (1.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-26 | Ashman Philip | Sell | 12 103 | Common Stock |
2024-03-11 | Werner Jason M. | Buy | 1 800 | Restricted Stock Units |
2024-03-11 | Wood Todd Michael | Buy | 125 000 | Performance-Based Restricted Stock Units |
2024-03-11 | Wood Todd Michael | Buy | 125 000 | Restricted Stock Units |
2024-03-11 | Eiswirth Richard S Jr | Buy | 14 700 | Restricted Stock Units |
INSIDER POWER |
---|
27.01 |
Last 77 transactions |
Buy: 33 555 909 | Sell: 20 075 544 |
Volume Correlation
Alimera Sciences Inc Correlation
10 Most Positive Correlations | |
---|---|
ADV | 0.943 |
RCMT | 0.942 |
BTWN | 0.941 |
AMZN | 0.933 |
USLM | 0.933 |
KE | 0.93 |
RXST | 0.929 |
HUSN | 0.928 |
MRAM | 0.928 |
ALTO | 0.928 |
10 Most Negative Correlations | |
---|---|
AKU | -0.948 |
IMBI | -0.942 |
AMRB | -0.936 |
RMBS | -0.93 |
STRM | -0.928 |
AGRI | -0.927 |
ENNV | -0.924 |
LOPE | -0.923 |
EYEN | -0.921 |
PTMN | -0.919 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alimera Sciences Inc Correlation - Currency/Commodity
Alimera Sciences Inc Financials
Annual | 2023 |
Revenue: | $80.75M |
Gross Profit: | $61.17M (75.75 %) |
EPS: | $-0.790 |
FY | 2023 |
Revenue: | $80.75M |
Gross Profit: | $61.17M (75.75 %) |
EPS: | $-0.790 |
FY | 2022 |
Revenue: | $54.13M |
Gross Profit: | $46.15M (85.26 %) |
EPS: | $-2.59 |
FY | 2021 |
Revenue: | $59.03M |
Gross Profit: | $52.00M (88.09 %) |
EPS: | $-0.854 |
Financial Reports:
No articles found.
Alimera Sciences Inc
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators